Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy
- PMID: 24508785
- DOI: 10.1167/iovs.13-12589
Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy
Abstract
Purpose: To investigate the effects of prostaglandin (PG) analogues on adipogenesis so as to clarify the mechanism of a side effect of topical PG analogues: deepening of the upper eyelid sulcus (DUES), which has been reported in this decade.
Methods: The 3T3-L1 preadipocytes were treated to promote differentiation into mature adipocytes. During the early and late stages of differentiation (days 0, 2, and 7), 1 to 1000 nM latanoprost acid (LAT-A), travoprost acid (TRA-A), tafluprost acid (TAF-A), bimatoprost (BIM), bimatoprost acid (BIM-A), unoprostone (UNO), or prostaglandin F2a (PGF2α) was applied to cells. Oil red O staining was used to detect intracellular lipids on day 10. Stained areas measured on a photograph were compared with those in control cultures. All experiments were performed in a masked manner. Next, similar experiments were performed using primary cultured mouse adipocytes from FP receptor knockout and wild-type mice.
Results: When PGs were added on day 0 or 2, LAT-A, TAF-A, BIM-A, and PGF2α significantly inhibited adipogenesis (P < 0.01 on day 0, P < 0.05 on day 2) at concentrations of 10 nM and 100 nM, and TRA-A inhibited adipogenesis only at 100 nM. Bimatoprost and UNO did not affect adipogenesis at any concentration. When PGs were added on day 7, 100 nM LAT-A, BIM-A, or PGF2α significantly suppressed adipogenesis (P < 0.05). In mouse primary adipocyte cultures, LAT-A, TAF-A, BIM-A, TRA-A, and PGF2α significantly suppressed adipogenesis in wild-type adipocytes (P < 0.05), but adipogenesis was not suppressed by any of the PG compounds in FP knockout mouse adipocytes.
Conclusions: Prostaglandin analogues have the potential to inhibit adipogenesis through FP receptor stimulation. Although these findings should be further analyzed in model systems more closely related to orbital fat, PG analogues may directly lead to reduced orbital fat by inhibiting adipogenesis.
Keywords: FP receptor; deepening of the upper eyelid sulcus; lipids; prostaglandins.
Similar articles
-
Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells.J Ocul Pharmacol Ther. 2020 Apr;36(3):162-169. doi: 10.1089/jop.2019.0079. Epub 2020 Jan 14. J Ocul Pharmacol Ther. 2020. PMID: 31934812 Free PMC article.
-
In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.J Ocul Pharmacol Ther. 2012 Apr;28(2):146-52. doi: 10.1089/jop.2011.0160. Epub 2011 Nov 22. J Ocul Pharmacol Ther. 2012. PMID: 22107041 Free PMC article.
-
Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.J Glaucoma. 2013 Oct-Nov;22(8):626-31. doi: 10.1097/IJG.0b013e31824d8d7c. J Glaucoma. 2013. PMID: 22936280
-
Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.J Ocul Pharmacol Ther. 2002 Aug;18(4):313-24. doi: 10.1089/10807680260218489. J Ocul Pharmacol Ther. 2002. PMID: 12222762
-
Prostaglandin D2 and F2α as Regulators of Adipogenesis and Obesity.Biol Pharm Bull. 2022;45(8):985-991. doi: 10.1248/bpb.b22-00210. Biol Pharm Bull. 2022. PMID: 35908908 Review.
Cited by
-
Prostaglandin-associated periorbitopathy.Indian J Ophthalmol. 2016 Jun;64(6):459. doi: 10.4103/0301-4738.187676. Indian J Ophthalmol. 2016. PMID: 27488155 Free PMC article. No abstract available.
-
Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution.Eye (Lond). 2014 Dec;28(12):1446-51. doi: 10.1038/eye.2014.224. Epub 2014 Sep 19. Eye (Lond). 2014. PMID: 25233818 Free PMC article.
-
Orbital Fat Volume After Treatment with Topical Prostaglandin Agonists.Invest Ophthalmol Vis Sci. 2020 May 11;61(5):46. doi: 10.1167/iovs.61.5.46. Invest Ophthalmol Vis Sci. 2020. PMID: 32455434 Free PMC article.
-
In Vivo Analysis of Prostaglandins-induced Ocular Surface and Periocular Adnexa Modifications in Patients with Glaucoma.In Vivo. 2018 Mar-Apr;32(2):211-220. doi: 10.21873/invivo.11227. In Vivo. 2018. PMID: 29475902 Free PMC article. Review.
-
Prostaglandin F2α agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix.Sci Rep. 2020 May 14;10(1):7958. doi: 10.1038/s41598-020-64674-1. Sci Rep. 2020. PMID: 32409724 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials